Cystic Fibrosis Therapeutics in Major Developed Markets to 2019

GBI Research has released its pharma report “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 – CFTR Modulators Initiate Drive Towards Personalized Treatment and Market Growth.” The value of the Cystic Fibrosis (CF) market is expected to increase significantly in value over the forecast period across the leading eight developed nations, from $695.6 million […]



from Africa Punch http://ift.tt/1g4v9c9

via IFTTThttp://ift.tt/1g4v9c9